Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China · Delayed Price · Currency is CNY 20.88
-1.11 (-5.05%)
Sep 26, 2025, 2:45 PM CST
SHA:600521 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 779.9 | 1,119 | 830.47 | 1,168 | 487.54 | 929.82 | Upgrade |
Depreciation & Amortization | 938.81 | 903.9 | 780.37 | 672.01 | 563.07 | 470.83 | Upgrade |
Other Amortization | 35.73 | 28.68 | 9.25 | 7.08 | 2.45 | 2.3 | Upgrade |
Loss (Gain) From Sale of Assets | -2.71 | -2.33 | 0.29 | -3.59 | -0.6 | -19.15 | Upgrade |
Asset Writedown & Restructuring Costs | 29.15 | 30.13 | 39.41 | 21.69 | 10.35 | 13.58 | Upgrade |
Loss (Gain) From Sale of Investments | -4.4 | 97.72 | 161.97 | 66.48 | -442.95 | -26.09 | Upgrade |
Provision & Write-off of Bad Debts | 29.56 | 36.58 | -7.93 | 45.37 | 14.73 | 29.6 | Upgrade |
Other Operating Activities | 283.8 | 229.27 | 241.69 | 86.91 | 220.3 | 378.16 | Upgrade |
Change in Accounts Receivable | -427.98 | -786.09 | 269.5 | -818.89 | -388.87 | -582.45 | Upgrade |
Change in Inventory | -477.93 | -78.33 | -140.05 | -679.92 | -386.81 | -184.07 | Upgrade |
Change in Accounts Payable | 49.66 | 597.68 | 19.99 | 669.89 | 679.92 | 589.22 | Upgrade |
Change in Other Net Operating Assets | 13.18 | 14.14 | -0.49 | 81.61 | 113.74 | 5.91 | Upgrade |
Operating Cash Flow | 1,244 | 2,173 | 2,217 | 1,243 | 938.43 | 1,555 | Upgrade |
Operating Cash Flow Growth | -52.58% | -2.00% | 78.41% | 32.42% | -39.67% | -11.32% | Upgrade |
Capital Expenditures | -1,835 | -1,853 | -1,592 | -2,316 | -2,434 | -1,276 | Upgrade |
Sale of Property, Plant & Equipment | 4.79 | 5.2 | 4.84 | 10.72 | 9.94 | 32.19 | Upgrade |
Investment in Securities | -74.1 | -72.57 | -18.7 | -106.66 | 58.19 | -113.69 | Upgrade |
Other Investing Activities | 0.16 | 0.43 | -16.53 | -20.35 | 9.48 | 0.44 | Upgrade |
Investing Cash Flow | -1,904 | -1,920 | -1,623 | -2,433 | -2,357 | -1,358 | Upgrade |
Long-Term Debt Issued | - | 6,202 | 3,321 | 3,873 | 3,238 | 6,134 | Upgrade |
Total Debt Issued | 4,569 | 6,202 | 3,321 | 3,873 | 3,238 | 6,134 | Upgrade |
Long-Term Debt Repaid | - | -5,637 | -3,321 | -2,732 | -1,931 | -5,135 | Upgrade |
Total Debt Repaid | -4,178 | -5,637 | -3,321 | -2,732 | -1,931 | -5,135 | Upgrade |
Net Debt Issued (Repaid) | 391.54 | 564.79 | -0.6 | 1,140 | 1,307 | 998.68 | Upgrade |
Issuance of Common Stock | 591.52 | - | - | 37.68 | 371.82 | - | Upgrade |
Repurchase of Common Stock | - | -189.92 | -71 | -172.43 | -150.01 | - | Upgrade |
Common Dividends Paid | -455.77 | -475.36 | -556.01 | -318.32 | -387.21 | -392.83 | Upgrade |
Other Financing Activities | 165.85 | -32.42 | -16.63 | -78.36 | -23.31 | -9.49 | Upgrade |
Financing Cash Flow | 693.14 | -132.91 | -644.23 | 609.04 | 1,118 | 596.35 | Upgrade |
Foreign Exchange Rate Adjustments | 15.17 | 51.16 | 29 | 54.65 | -43.49 | -85.34 | Upgrade |
Net Cash Flow | 48.99 | 170.63 | -20.98 | -526.18 | -343.57 | 708.93 | Upgrade |
Free Cash Flow | -590.17 | 319.33 | 624.63 | -1,074 | -1,496 | 278.97 | Upgrade |
Free Cash Flow Growth | - | -48.88% | - | - | - | -70.93% | Upgrade |
Free Cash Flow Margin | -6.60% | 3.35% | 7.52% | -12.99% | -22.52% | 4.30% | Upgrade |
Free Cash Flow Per Share | -0.40 | 0.22 | 0.43 | -0.73 | -1.04 | 0.19 | Upgrade |
Cash Interest Paid | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | - | Upgrade |
Cash Income Tax Paid | 476.51 | 568.31 | 614.3 | 206.43 | 227.84 | 117.59 | Upgrade |
Levered Free Cash Flow | -1,004 | -474.18 | 15.26 | -1,715 | -1,721 | -39.98 | Upgrade |
Unlevered Free Cash Flow | -865.4 | -336.8 | 160.07 | -1,578 | -1,617 | 44.6 | Upgrade |
Change in Working Capital | -845.36 | -270.27 | 161.5 | -821.02 | 83.55 | -223.58 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.